Eltrombopag Use in Children with Persistent and Chronic Primary Immune Thrombocytopenia in a Portuguese Pediatric Center
N/a.
Main Authors: | Caroline Lopes, Ana Castro, Raquel Maia, Sara Batalha, Paula Kjöllerström |
---|---|
Format: | Article |
Language: | English |
Published: |
Ordem dos Médicos
2024-04-01
|
Series: | Acta Médica Portuguesa |
Subjects: | |
Online Access: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20532 |
Similar Items
-
Clinical Presentation and Therapy of Primary Immune Thrombocytopenia Resistant to Splenectomy
by: Aleksandar Kara-Jovanović, et al.
Published: (2020-04-01) -
Advances in management of pediatric chronic immune thrombocytopenia: a narrative review
by: Jae Min Lee
Published: (2023-07-01) -
Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency
by: Laura Scaramucci, et al.
Published: (2016-02-01) -
Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01) -
Re-Visiting Immune Thrombocytopenia with Covid-19 Vaccination: A Case Report
by: Abhishek Samprathi, et al.
Published: (2022-03-01)